Patient Guide · Living Kidney Donation · Transplant

Can I Donate a Kidney? Eligibility & Your Long-Term Outlook

Many healthy adults can live well with one kidney, but no webpage can clear someone to donate. Use this guide to understand the usual screening steps, identify issues that need specialist review, estimate baseline kidney-failure risk, and prepare for a transplant-center evaluation.

Published: References: 7 Read time:

Download the PDF guide ↓  ·  All calculators & tools  ·  Kidney Failure Risk Equation →

Start here: could I be a kidney donor?

Possibly - if you are an adult in good overall health, have adequate kidney function, and are choosing freely. The transplant team must confirm kidney anatomy, blood and urine results, blood pressure, metabolic health, infection and cancer screening, mental readiness, social support, and compatibility. Different programs may reach different decisions in borderline cases.

Check my baseline risk factors ↓ Download printable PDF
Before you begin
  1. Use recent, confirmed results if available. If you do not know your eGFR or urine ACR, ask for kidney screening rather than guessing.
  2. The tool classifies the candidate's baseline projected ESRD risk tier (the risk without donation) and counts how many adverse risk factors are present. The tier updates automatically as you change any field.
  3. For the exact projected 15-year and lifetime percentage, open the authoritative OPTN/UNOS tool at transplantmodels.com/esrdrisk — it implements the full Grams (NEJM 2016) competing-risk model. This page deliberately does not reproduce that exact percentage.
  4. This is a conversation starter, not medical clearance. A favorable screen means “reasonable to ask a transplant center,” not “approved to donate.”

All computation runs in your browser; no values are stored or transmitted.

When to Use

Use this tool during the evaluation of a prospective living kidney donor to frame the candidate's baseline (pre-donation) long-term risk of ESRD. KDIGO and OPTN policy require that programs assess and disclose this projected risk during informed consent. The Grams (NEJM 2016) model — the basis of the OPTN/UNOS calculator at transplantmodels.com — projects the candidate's 15-year and lifetime risk of kidney failure in the absence of donation, which programs then weigh against their acceptance thresholds (and against the incremental risk that donation itself adds).

✅

Appropriate population

Adults being evaluated as prospective living kidney donors, where the transplant team needs a structured baseline-risk estimate to support candidate counseling and the program's acceptance decision. Useful as a quick triage of who is clearly low-risk versus who carries adverse factors that warrant the exact projected percentage and a careful program discussion.

⚠️

When NOT to rely on it

This page is a risk-factor classifier and counseling aid — not a substitute for the exact projected percentage. It does not reproduce the Grams competing-risk model's calibrated 15-year/lifetime numbers; for those, use the authoritative tool at transplantmodels.com. The model estimates baseline risk without donation, not the post-donation risk (which is higher). It was derived predominantly in US/general-population cohorts and may not transport perfectly to all populations. It does not replace program-specific policy, complete medical evaluation, or individualized informed consent.

Pearls & Pitfalls
💡

Baseline risk is reassuringly low in healthy candidates

In the Grams model, a healthy 40-year-old's projected 15-year ESRD risk in the absence of donation is very low — about 0.24% in Black men, 0.15% in Black women, 0.06% in White men, and 0.04% in White women. These published reference values anchor counseling: most acceptable candidates sit near this floor, and adverse factors move the estimate upward.

🔬

The factors that raise projected risk

Risk rises with lower eGFR, higher albuminuria, hypertension (and antihypertensive use), diabetes, obesity, current/former smoking, younger age (more years of follow-up at risk), male sex, and Black race. The model accounts for the competing risk of death, so its lifetime estimates are not simply 15-year risk scaled up. Diabetes and clearly reduced eGFR are, in most programs, near-absolute contraindications regardless of the computed number.

🚫

Pitfalls

(1) This tool gives a risk tier, not the exact percentage — always obtain the calibrated 15-year/lifetime figure from transplantmodels.com before counseling on numbers. (2) It estimates pre-donation baseline risk; donation adds incremental lifetime risk on top, so do not present the baseline as the post-donation risk. (3) A "low" projected risk does not by itself clear a candidate — anatomy, hereditary disease (e.g., relatives with ADPKD or APOL1-related disease), psychosocial factors, and program policy all matter. (4) Garbage in, garbage out: use a reliable measured/estimated GFR and a confirmed urine ACR, not single transient values.

Why Use It

Living kidney donation asks a healthy person to accept a small but real long-term risk for someone else's benefit, so quantifying that risk is an ethical and regulatory cornerstone of donor evaluation. Before the Grams (NEJM 2016) framework, programs counseled donors with crude, population-average figures. The model — calibrated to US ESRD incidence and accounting for the competing risk of death — projects an individual candidate's 15-year and lifetime risk of kidney failure in the absence of donation from ten baseline characteristics, giving the team and the candidate a concrete, individualized baseline against which the incremental risk of donation can be weighed. KDIGO's living-donor guideline and OPTN policy explicitly endorse using this projected baseline risk during evaluation and informed consent. This page operationalizes that thinking quickly, then routes you to the authoritative calculator for the exact number.

Could I be considered? Baseline risk screen

Enter the prospective donor's baseline characteristics. The result sorts findings into a discussion tier and identifies issues needing transplant-team review. It does not approve or reject a donor and does not compute the exact Grams-model percentage.

Required. Candidate's current age. Younger age = more years at risk.
Required.
Required by the US-derived Grams model. Filipino and other Asian candidates fall under “non-Black,” but this does not guarantee accurate local calibration.
Required. Measured or estimated GFR.
Required. Baseline systolic BP.
Treated hypertension adds risk independent of the BP value.
Required. Obesity (≥30) raises projected risk.
Diabetes markedly raises risk; usually a contraindication.
Current smoking adds risk.
Higher albuminuria raises projected risk.
—
Discussion Tier
pre-donation
—
Adverse Factors
present
—
Published 15-yr Reference
healthy 40-yr-old
For the exact projected percentage

This tool gives a risk tier, not the calibrated number. Open the authoritative OPTN/UNOS ESRD Risk Tool — which implements the full Grams (NEJM 2016) competing-risk model — to obtain the exact 15-year and lifetime projected baseline ESRD risk:
Open transplantmodels.com/esrdrisk →

⚕ Educational screening only. The Grams model was derived mainly from US general-population data and estimates baseline risk without donation; it is not a Filipino-specific model and does not capture all inherited, anatomical, surgical, or psychosocial risks. Donation adds incremental lifetime risk. Only a transplant program can determine eligibility.

How the transplant team answers “Can I donate?”

The decision is deliberately staged. A concern at one step may lead to repeat testing, treatment, genetic counseling, or a program-specific decision rather than an automatic rejection.

1

Confirm a free, informed choice

You must be an adult able to consent, understand the risks, and be free from payment, pressure, or coercion. An independent donor advocate or equivalent team member protects your interests.

2

Look for conditions that usually stop donation

Active serious infection or cancer, uncontrolled hypertension, significant kidney disease or protein in the urine, inadequate kidney function, and certain uncontrolled medical or psychiatric conditions commonly prevent donation. Diabetes and obesity require individualized program review.

3

Measure your personal lifetime risk

The team confirms GFR, urine albumin, blood pressure (sometimes ambulatory monitoring), glucose, BMI, smoking history, family history, and possible hereditary kidney disease. Young age means more years for risk to accumulate.

4

Check anatomy, compatibility, and surgical fitness

Kidney imaging, blood-group and tissue testing, heart and anesthesia assessment, infection screening, and age-appropriate cancer screening determine whether donation can be performed safely. Paired exchange may help when donor and recipient are incompatible.

5

Review psychosocial and practical readiness

The team discusses mental health, expectations, family support, work and recovery, costs, future insurance considerations, and what happens if the transplant does not work. You may withdraw at any time.

6

Shared decision and lifelong follow-up plan

The transplant program compares your estimated risk with its acceptance threshold and explains uncertainty. If approved, plan annual blood pressure, weight, creatinine/eGFR, and urine albumin checks after donation.

⚠️

Do not donate on the strength of an online result

Only an accredited transplant program can decide whether donation is acceptable for you. Seek urgent care for chest pain, severe shortness of breath, fainting, or other acute symptoms; this tool is not designed for emergencies.

What may happen to me in the long term?

Kidney function

GFR falls after one kidney is removed, then the remaining kidney adapts. Many carefully selected donors remain healthy, but their measured kidney function is lower than it would have been with two kidneys.

Kidney failure

The absolute risk remains low in well-screened donors, but donation adds some risk above the person’s pre-donation baseline. Online models cannot fully predict this added risk for every ancestry or lifetime.

Blood pressure

Blood pressure may rise with aging, and some donors develop hypertension. Annual checks matter because early treatment protects the remaining kidney.

Pregnancy

Most post-donation pregnancies are uncomplicated, but gestational hypertension or preeclampsia is more frequent than in similarly healthy non-donors. Discuss future pregnancy plans before donation and arrange obstetric monitoring.

Quality of life

Most donors report good quality of life and satisfaction. A minority experience pain, fatigue, emotional distress, financial strain, or regret, especially if recovery or the recipient’s outcome differs from expectations.

Every year, for life

Check blood pressure, weight/BMI, serum creatinine with eGFR, and urine albumin. Avoid smoking, maintain activity and a healthy weight, and review medicines that may affect kidney health.

Numbers need context. In a Canadian matched cohort, gestational hypertension or preeclampsia occurred in 11% of post-donation pregnancies versus 5% among healthy non-donors. In a long-term US donor cohort, most donors had preserved kidney function and excellent quality of life, but observational studies have limits and healthier people are selected to donate.

What the Taiwan experience adds - and what it does not

The 2026 Kidney International article Hear My Last Wish concerns deceased organ donation, not eligibility or long-term outcomes after living kidney donation. Taiwan’s initiative lets people record authenticated voice messages about their donation wishes so families can hear the donor’s intent during time-sensitive consent discussions.

The program was implemented across 42 transplant hospitals and reported encouraging preliminary increases in consent activity and successful donations. Because the system used anonymous aggregate data, it could not show whether an individual voice recording caused a family to consent. Its transferable lesson for the Philippines is the value of discussing donation wishes early, documenting them clearly, and respecting family and cultural context - while preserving voluntariness, privacy, authenticity, and trained support for grieving families.

🗣️

For a living donor, your own voice still matters

Tell the transplant team what you understand, why you want to donate, what worries you, and what would make you stop. Consent is an ongoing process, and you can change your mind before surgery.

Next Steps

Use the baseline risk tier to direct counseling and the program's evaluation pathway.

  • Get the exact number. Always confirm the calibrated 15-year and lifetime projected baseline risk on the OPTN/UNOS ESRD Risk Tool before counseling a candidate on figures.
  • Compare against your program's acceptance thresholds and OPTN policy. Many programs use projected-risk thresholds, often interpreted with age (a young candidate accumulates more years of risk).
  • Counsel on the incremental risk of donation. The projection is baseline (without donation); donation adds lifetime ESRD risk on top of it — discuss both figures explicitly.
  • Address contraindications and modifiers the model does not capture: diabetes, clearly reduced GFR, significant albuminuria, hereditary kidney disease in the family, APOL1-related risk, and psychosocial factors.
  • Pair this with the Kidney Failure Risk Equation and an accurate eGFR (CKD-EPI 2021) when assessing candidate kidney function.
Evidence & References

Model & baseline reference risks

Grams et al. used meta-analyzed risk associations from seven general-population cohorts, calibrated to US ESRD and mortality incidence, and projected baseline 15-year and lifetime ESRD risk (in the absence of donation) using competing-risk methods. The model is the basis of the OPTN/UNOS calculator at transplantmodels.com. The published 15-year reference risks for a healthy 40-year-old (no risk factors) are shown below.

Healthy 40-year-oldProjected 15-yr baseline ESRD risk
Black men0.24%
Black women0.15%
White men0.06%
White women0.04%

Risk factors used in the projection

FactorDirection of effect on projected risk
Lower eGFR↑ risk
Higher albuminuria (ACR)↑ risk
Hypertension / antihypertensive use↑ risk
Diabetes↑↑ risk (usually a contraindication)
Obesity (higher BMI)↑ risk
Current / former smoking↑ risk
Younger age↑ lifetime risk (more years at risk)
Male sex; Black race↑ risk

This page implements the published risk factors and reference values as a qualitative classifier; it does not reproduce the model's exact calibrated coefficients or percentages, which should be obtained from the authoritative calculator.

References

  1. Grams ME, Sang Y, Levey AS, et al. Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med. 2016;374(5):411–421. doi:10.1056/NEJMoa1510491.
  2. Lentine KL, Kasiske BL, Levey AS, et al. KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation. 2017;101(8S):S1–S109. (See also OPTN policy on living donor evaluation.)
  3. Massie AB, Muzaale AD, Luo X, et al. Quantifying Postdonation Risk of ESRD in Living Kidney Donors. J Am Soc Nephrol. 2017;28(9):2749–2755. doi:10.1681/ASN.2016101084.
  4. Ibrahim HN, Foley R, Tan L, et al. Long-Term Consequences of Kidney Donation. N Engl J Med. 2009;360:459–469. doi:10.1056/NEJMoa0804883.
  5. Garg AX, Nevis IF, McArthur E, et al. Gestational Hypertension and Preeclampsia in Living Kidney Donors. N Engl J Med. 2015;372:124–133. doi:10.1056/NEJMoa1408932.
  6. O'Keeffe LM, Ramond A, Oliver-Williams C, et al. Mid- and Long-Term Health Risks in Living Kidney Donors: A Systematic Review and Meta-analysis. Ann Intern Med. 2018;168:276–284. doi:10.7326/M17-1235.
  7. Tsai H-B, Yang F-J, Lee M-C. The Hear My Last Wish initiative: leveraging voiceprint technology to bridge the gap between donor intent and family consent in Taiwan. Kidney Int. 2026;110:566–569. doi:10.1016/j.kint.2026.04.040.
Important: This calculator is an educational aid for licensed clinicians and does not replace individualized living-donor evaluation. It is a qualitative risk-factor classifier based on the Grams et al. (NEJM 2016) factors — it does not compute the model's exact calibrated 15-year or lifetime percentages. For the authoritative projected baseline ESRD risk, use the OPTN/UNOS tool at transplantmodels.com/esrdrisk. The projection estimates risk in the absence of donation; donation incrementally raises lifetime ESRD risk, so the post-donation figure is higher. Always integrate the result with the complete medical evaluation, family and hereditary-disease history, psychosocial assessment, program policy, and OPTN/KDIGO guidance, and obtain individualized informed consent before any donation decision.
References 7 sources
  1. Grams ME, et al. Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med. 2016;374(5):411–421.
  2. Lentine KL, et al. KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation. 2017. (OPTN living donor evaluation policy.)
  3. Massie AB, et al. Quantifying Postdonation Risk of ESRD in Living Kidney Donors. J Am Soc Nephrol. 2017;28(9):2749–2755.
  4. Ibrahim HN, et al. Long-Term Consequences of Kidney Donation. N Engl J Med. 2009;360:459–469.
  5. Garg AX, et al. Gestational Hypertension and Preeclampsia in Living Kidney Donors. N Engl J Med. 2015;372:124–133.
  6. O'Keeffe LM, et al. Mid- and Long-Term Health Risks in Living Kidney Donors. Ann Intern Med. 2018;168:276–284.
  7. Tsai H-B, et al. The Hear My Last Wish initiative. Kidney Int. 2026;110:566–569.
Dr. W Rivero, MD

W Rivero, MD, FPCP, DPSN

Specialist in Internal Medicine, Nephrology, and Clinical Nutrition. Practicing integrative and evidence-based nephrology across Quezon City, Pampanga, and Bulacan.

· Book an Appointment →

QR code — scan to save Dr. Rivero's contact info

Scan and save

All Calculators Related Guides